Encoded Therapeutics is Drug Discovery in United States that focus on therapy pipeline business. Founded in 2014. They cover business area such as developer, precision gene therapy, treatment, severe genetic disorder, devastating genetic and acquire disorder, multiple disease pathway, neurocircuitry, metabolic disorder, neurodegeneration, cardiovascular disease, medical practitioner, patient, their life.
2014
( 10 years old in 2024 )
Therapy Pipeline
-
341 Oyster Point Boulevard
Suite 100
South San Francisco, CA 94080
United States
Private
developerprecision gene therapytreatmentsevere genetic disorderdevastating genetic and acquire disordermultiple disease pathwayneurocircuitrymetabolic disorderneurodegenerationcardiovascular diseasemedical practitionerpatienttheir life
* We use standard office opening hours in near Encoded Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Encoded Therapeutics is Drug Discovery business from United States that founded in 2014 (10 years old in 2024), Encoded Therapeutics business is focusing on Therapy Pipeline.
Encoded Therapeutics headquarter office and corporate office address is located in 341 Oyster Point Boulevard Suite 100 South San Francisco, CA 94080 United States.
Encoded Therapeutics was founded in United States.
In 2024, Encoded Therapeutics is currently focus on therapy pipeline sector.
Above is snippet of Google Trends for "therapy pipeline" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Encoded Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
